Related references
Note: Only part of the references are listed.The Putative Role of mTOR Inhibitors in Non-tuberous Sclerosis Complex-Related Epilepsy
Hannah E. Goldstein et al.
FRONTIERS IN NEUROLOGY (2021)
Convergent and Divergent Mechanisms of Epileptogenesis in mTORopathies
Lena H. Nguyen et al.
FRONTIERS IN NEUROANATOMY (2021)
PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability
Tanveer Singh et al.
METABOLIC BRAIN DISEASE (2021)
The potential effects of anticonvulsant drugs on neuropeptides and neurotrophins in pentylenetetrazol kindled seizures in the rat
Hasan Tekgul et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2020)
Neuroprotective effect of PPAR alpha and gamma agonists in a mouse model of amyloidogenesis through modulation of the Wnt/beta catenin pathway via targeting alpha- and beta-secretases
Naglaa Assaf et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)
Donepezil improves neuropathy through activation of AMPK signalling pathway in streptozotocin-induced diabetic mice
Mangreed M. Atef et al.
BIOCHEMICAL PHARMACOLOGY (2019)
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis
Hannah V. Woodcock et al.
NATURE COMMUNICATIONS (2019)
Mechanisms of AMPK in the maintenance of ATP balance during energy metabolism
Rong Ke et al.
CELL BIOLOGY INTERNATIONAL (2018)
Pentylenetetrazole-Induced Kindling Mouse Model
Tadayuki Shimada et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Targeted profiling of RNA translation reveals mTOR-4EBP1/2-independent translation regulation of mRNAs encoding ribosomal proteins
Ben B. Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Nerve growth factor-induced Akt/mTOR activation protects the ischemic heart via restoring autophagic flux and attenuating ubiquitinated protein accumulation
Zhou-Guang Wang et al.
ONCOTARGET (2017)
Nonsteroidal anti-inflammatory drugs in clinical and experimental epilepsy
Beatrice Mihaela Radu et al.
EPILEPSY RESEARCH (2017)
Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery
I. Blumcke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Intranasal nerve growth factor attenuating the seizure onset via p75R/Caspase pathway in the experimental epilepsy
Jing'an Lei et al.
BRAIN RESEARCH BULLETIN (2017)
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis
Rita Citraro et al.
PHARMACOLOGICAL RESEARCH (2016)
Effect of Pioglitazone on Excitotoxic Neuronal Damage in the Mouse Hippocampus
Choong Hyun Lee et al.
BIOMOLECULES & THERAPEUTICS (2015)
mTOR Inhibition in Epilepsy: Rationale and Clinical Perspectives
Adam P. Ostendorf et al.
CNS DRUGS (2015)
Peroxisome proliferator-activated receptor-γ agonist inhibits the mammalian target of rapamycin signaling pathway and has a protective effect in a rat model of status epilepticus
Yong-Zhi San et al.
MOLECULAR MEDICINE REPORTS (2015)
Current Research on Antiepileptic Compounds
Cheng-Xi Wei et al.
MOLECULES (2015)
Role of mTOR inhibitors in epilepsy treatment
Krzysztof Sadowski et al.
PHARMACOLOGICAL REPORTS (2015)
Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine
Janaina K. Barbiero et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Suppression of Feedback Loops Mediated by PI3K/mTOR Induces Multiple Overactivation of Compensatory Pathways: An Unintended Consequence Leading to Drug Resistance
Enrique Rozengurt et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Sub-chronic treatment with pioglitazone exerts anti-convulsant effects in pentylenetetrazole-induced seizures of mice: The role of nitric oxide
Hamed Shafaroodi et al.
BRAIN RESEARCH BULLETIN (2012)
Influence of calcium channel blockers on anticonvulsant and antinociceptive activities of valproic acid in pentylenetetrazole-kindled mice
Mona F. El-Azab et al.
PHARMACOLOGICAL REPORTS (2012)
Limitations in Small Intestinal Neuroendocrine Tumor Therapy by mTor Kinase Inhibition Reflect Growth Factor-Mediated PI3K Feedback Loop Activation via ERK1/2 and AKT
Bernhard Svejda et al.
CANCER (2011)
Anticonvulsant potential of the peroxisome proliferator-activated receptor gamma agonist pioglitazone in pentylenetetrazole-induced acute seizures and kindling in mice
Dalaal M. Abdallah
BRAIN RESEARCH (2010)
Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy
Xiaoxing Huang et al.
NEUROBIOLOGY OF DISEASE (2010)
Anticonvulsant and Antiepileptic Actions of 2-Deoxy-D-Glucose in Epilepsy Models
Carl E. Stafstrom et al.
ANNALS OF NEUROLOGY (2009)
Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer's disease and decreases it in wild-type mice
E. Galea et al.
DIABETOLOGIA (2006)
Ameliorative effect of pioglitazone on seizure responses in genetically epilepsy-susceptible EL mice
Kazumasa Okada et al.
BRAIN RESEARCH (2006)
Pentylenetetrazol-induced status epilepticus up-regulates the expression of glucose transporter mRNAs but not proteins in the immature rat brain
A Nehlig et al.
BRAIN RESEARCH (2006)
Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade
YJ Shi et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity
A Hahn-Windgassen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Amiloride protects against pentylenetetrazole-induced kindling in mice
A Ali et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Early identification of refractory epilepsy.
P Kwan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)